Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Maurine Delhaye"'
Autor:
Mathieu Hubert, Florence Guivel-Benhassine, Timothée Bruel, Françoise Porrot, Delphine Planas, Jessica Vanhomwegen, Aurélie Wiedemann, Sonia Burrel, Stéphane Marot, Romain Palich, Gentiane Monsel, Harouna Diombera, Sébastien Gallien, Jose Luis Lopez-Zaragoza, William Vindrios, Fabien Taieb, Sandrine Fernandes-Pellerin, Maurine Delhaye, Hélène Laude, Laurence Arowas, Marie-Noelle Ungeheuer, Laurent Hocqueloux, Valérie Pourcher, Thierry Prazuck, Anne-Geneviève Marcelin, Jean-Daniel Lelièvre, Christophe Batéjat, Yves Lévy, Jean-Claude Manuguerra, Olivier Schwartz
Publikováno v:
Cell Host & Microbe.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8528997b23be702cbfe7dd18d230045
https://doi.org/10.1016/j.chom.2023.05.001
https://doi.org/10.1016/j.chom.2023.05.001
Autor:
Mathieu Hubert, Florence Guivel-Benhassine, Timothée Bruel, Françoise Porrot, Delphine Planas, Jessica Vanhomwegen, Aurélie Wiedemann, Sonia Burrel, Stéphane Marot, Romain Palich, Gentiane Monsel, Harouna Diombera, Sébastien Gallien, Jose Luis Lopez-Zaragoza, William Vindrios, Fabien Taieb, Sandrine Fernandes-Pellerin, Maurine Delhaye, Hélène Laude, Laurence Arowas, Marie-Noelle Ungeheuer, Laurent Hocqueloux, Valérie Pourcher, Thierry Prazuck, Anne-Geneviève Marcelin, Jean-Daniel Lelièvre, Christophe Batéjat, Yves Lévy, Jean-Claude Manuguerra, Olivier Schwartz
Mpox virus (MPXV) caused a multi-country outbreak in non-endemic areas in 2022. The Modified Vaccinia Ankara (MVA)-based vaccine was used as prophylaxis, but its effectiveness remains poorly characterized. Here, we developed two assays for quantifica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf468c3dc34116ea5d42348d5967ea3f
https://doi.org/10.1101/2023.04.14.23288385
https://doi.org/10.1101/2023.04.14.23288385
Publikováno v:
Molecular Pharmacology. 72:1497-1507
The chemokine receptor 5 (CCR5), a member of the G protein-coupled receptor family (GPCR), is used by human immunodeficiency virus type 1 (HIV-1) with a R5 tropism as an entry receptor in addition to CD4. It is a key target for an antiviral action ai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::359450e7847c032c0f44cfaddbb36c3c
https://doi.org/10.1124/mol.107.038422
https://doi.org/10.1124/mol.107.038422